Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells
Quantifying the DNA Damage Response in Clinical Grade Pluripotent Stem Cells; An Efficient, Highly Sensitive Means of Establishing a Quality Control Standard in Large Scale Pluripotent Stem Cell Production.
ReGen Theranostics, Inc.
Matt Nelson
2015-2016